[go: up one dir, main page]

NO2462158T3 - - Google Patents

Info

Publication number
NO2462158T3
NO2462158T3 NO10740823A NO10740823A NO2462158T3 NO 2462158 T3 NO2462158 T3 NO 2462158T3 NO 10740823 A NO10740823 A NO 10740823A NO 10740823 A NO10740823 A NO 10740823A NO 2462158 T3 NO2462158 T3 NO 2462158T3
Authority
NO
Norway
Application number
NO10740823A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42985499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2462158(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2462158T3 publication Critical patent/NO2462158T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Water Supply & Treatment (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO10740823A 2009-08-06 2010-08-06 NO2462158T3 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23181109P 2009-08-06 2009-08-06
PCT/US2010/044760 WO2011031397A1 (en) 2009-08-06 2010-08-06 Method to improve virus removal in protein purification

Publications (1)

Publication Number Publication Date
NO2462158T3 true NO2462158T3 (ja) 2018-06-09

Family

ID=42985499

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10740823A NO2462158T3 (ja) 2009-08-06 2010-08-06

Country Status (25)

Country Link
US (4) US10662237B2 (ja)
EP (2) EP3309168A1 (ja)
JP (6) JP2013501075A (ja)
KR (3) KR20180035936A (ja)
CN (2) CN102712691A (ja)
AU (1) AU2010292897B2 (ja)
BR (1) BR112012002574A2 (ja)
CA (1) CA2770235C (ja)
DK (1) DK2462158T3 (ja)
ES (1) ES2662529T3 (ja)
HR (1) HRP20180309T1 (ja)
HU (1) HUE038451T2 (ja)
IL (3) IL217740B (ja)
LT (1) LT2462158T (ja)
MX (1) MX346115B (ja)
MY (1) MY188566A (ja)
NO (1) NO2462158T3 (ja)
NZ (1) NZ597809A (ja)
PL (1) PL2462158T3 (ja)
PT (1) PT2462158T (ja)
RU (1) RU2573894C2 (ja)
SG (1) SG178276A1 (ja)
SI (1) SI2462158T1 (ja)
WO (1) WO2011031397A1 (ja)
ZA (1) ZA201200626B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2527425A1 (en) 2006-09-13 2012-11-28 Abbott Laboratories Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
NZ592095A (en) 2008-10-20 2013-01-25 Abbott Lab Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
WO2010048192A2 (en) 2008-10-20 2010-04-29 Abbott Laboratories Viral inactivation during purification of antibodies
NO2462158T3 (ja) 2009-08-06 2018-06-09
TW201302793A (zh) 2010-09-03 2013-01-16 Glaxo Group Ltd 新穎之抗原結合蛋白
EP2697369B1 (en) * 2011-03-25 2018-06-27 F.Hoffmann-La Roche Ag Novel protein purification methods
DE102011105525B4 (de) * 2011-06-24 2015-03-26 Sartorius Stedim Biotech Gmbh Verfahren zur Abtrennung von Biopolymer-Aggregaten und Viren aus einem Fluid
US9096648B2 (en) * 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
CN104125963B (zh) 2011-12-22 2018-08-17 弗·哈夫曼-拉罗切有限公司 使用离子交换膜层析改进下游蛋白质纯化步骤的方法
AU2014318615B2 (en) 2013-09-13 2020-03-12 Genentech, Inc. Methods and compositions comprising purified recombinant polypeptides
PL3044323T3 (pl) 2013-09-13 2022-06-27 F.Hoffmann-La Roche Ag Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych
DK3209767T3 (da) * 2014-10-21 2020-11-02 Gennova Biopharmaceuticals Ltd Hidtil ukendt oprensningsfremgangsmåde til isolering og kommerciel fremstilling af rekombinant tnk-tpa (tenecteplase)
US20180072769A1 (en) * 2015-03-23 2018-03-15 Alexion Pharmaceuticals, Inc. Virus filtration
EP3639911B1 (en) * 2017-06-12 2024-07-31 Asahi Kasei Medical Co., Ltd. Filtration method for protein-containing liquid
IL275418B2 (en) * 2017-12-21 2024-07-01 Genzyme Corp Methods for improved removal of impurities during protein A chromatography
EA202192108A1 (ru) * 2019-01-28 2021-10-21 Эмджен Инк. Непрерывный способ изготовления для изготовления биопрепаратов посредством интеграции процессов получения лекарственного вещества и лекарственного препарата

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
WO1981001145A1 (en) 1979-10-18 1981-04-30 Univ Illinois Hydrolytic enzyme-activatible pro-drugs
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
JP2755395B2 (ja) 1987-09-23 1998-05-20 ブリストル―マイアーズ スクイブ コムパニー Ｈｉｖ感染細胞に殺作用する抗体異種結合体
WO1989005859A1 (en) 1987-12-21 1989-06-29 The Upjohn Company Agrobacterium mediated transformation of germinating plant seeds
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
JPH02198687A (ja) 1989-01-26 1990-08-07 Asahi Chem Ind Co Ltd 純水の製造方法
JPH038759A (ja) 1989-03-16 1991-01-16 Sumitomo Metal Ind Ltd 半導体磁器物質
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
CA2062795A1 (en) 1989-06-29 1990-12-30 Michael W. Fanger Bispecific reagents for aids therapy
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
DK0814159T3 (da) 1990-08-29 2005-10-24 Genpharm Int Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
US6407213B1 (en) 1991-06-14 2002-06-18 Genentech, Inc. Method for making humanized antibodies
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
WO1994004690A1 (en) 1992-08-17 1994-03-03 Genentech, Inc. Bispecific immunoadhesins
NZ269375A (en) * 1993-07-09 1997-11-24 T Cell Sciences Inc Chromatographic method of purifying complement receptor protein
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
ATE175975T1 (de) 1993-09-21 1999-02-15 Hemosol Inc Verdrängungschromatographisches verfahren und gereinigtes hämoglobin
JP3415222B2 (ja) 1993-10-20 2003-06-09 東洋濾紙株式会社 エンドトキシン吸着能を有するポリエーテルサルホン又はスルホン化ポリエーテルサルホン微孔膜
JP3453623B2 (ja) 1994-03-30 2003-10-06 サンスター株式会社 エンドトキシン吸着除去剤および除去方法
KR100378500B1 (ko) 1994-07-28 2003-05-22 밀리포어 코포레이션 복합다공성막및형성방법
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
FR2737730B1 (fr) * 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
EP0880536B2 (de) 1996-02-06 2015-08-05 Roche Diagnostics GmbH Verfahren zur herstellung von gereinigter nukleinsäure und deren verwendung
TW505655B (en) 1997-10-14 2002-10-11 Tanox Inc Enhanced aggregate removal from bulk-biologicals using ion exchange chromatography
GB9907553D0 (en) 1999-04-01 1999-05-26 Cantab Pharma Res Purification of biological preparations
DE60028210T2 (de) 1999-07-30 2007-03-08 Genentech, Inc., South San Francisco Geladene filtrationmembranen und deren verwendungen
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
US6806355B2 (en) 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
US7118675B2 (en) * 2002-02-04 2006-10-10 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
ES2545067T3 (es) 2002-04-26 2015-09-08 Genentech, Inc. Purificación de proteínas basada en la no afinidad
CN102050865B (zh) 2002-09-13 2014-03-12 拜奥根Idec公司 通过模拟移动床层析纯化多肽的方法
EP1403274A1 (en) 2002-09-30 2004-03-31 Meristem Therapeutics Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby
US20040116676A1 (en) 2002-09-30 2004-06-17 Hotta Joann Methods for removal of contaminants from blood product solutions
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1614693A4 (en) 2003-03-31 2006-07-19 Kirin Brewery Purification of a human monoclonal antibody and human polyclonal antibody
KR101224235B1 (ko) 2003-04-11 2013-01-25 메디뮨 엘엘씨 재조합 ｉｌ­９ 항체 및 그의 용도
KR101151477B1 (ko) * 2003-12-10 2012-06-22 메다렉스, 인코포레이티드 인터페론 알파 항체 및 그의 용도
AU2005209360B2 (en) 2004-01-30 2009-06-25 Takeda Pharmaceutical Company Limited Production and purification of recombinant arylsulfatase A
BRPI0507298A (pt) 2004-01-30 2007-07-03 Suomen Punainen Risti Veripalv processo para a produção de imunoglobulina segura a vìrus
US7390403B2 (en) 2004-03-19 2008-06-24 Millipore Corporation Prefilter system for biological systems
WO2006042541A1 (en) 2004-10-21 2006-04-27 Statens Serum Institut A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method
US20090117103A1 (en) 2005-03-08 2009-05-07 Pharmacia & Upjohn Company Llc M-CSF Antibody compositions Having Reduced Levels of Endotoxin
AU2007227700A1 (en) * 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
EP1854810A1 (en) 2006-05-09 2007-11-14 PanGenetics B.V. Deimmunized antagonistic anti-human CD40 monoclonal antibody from the ch5D12 antibody
EP2069387A4 (en) * 2006-06-14 2011-02-02 Glaxosmithkline Llc METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC
EA017733B1 (ru) 2006-08-28 2013-02-28 Арес Трейдинг С.А. СПОСОБ ОЧИСТКИ Fc-СЛИТЫХ БЕЛКОВ
WO2008036899A2 (en) 2006-09-22 2008-03-27 Amgen Inc. Methods for removing viral contaminants during protein purification
DK2087002T3 (da) 2006-10-27 2014-10-27 Lpath Inc Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat
WO2008073620A2 (en) 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
CN101535469A (zh) 2006-11-08 2009-09-16 惠氏公司 合理设计的细胞培养基
ES2624185T3 (es) 2007-04-26 2017-07-13 Chugai Seiyaku Kabushiki Kaisha Método de cultivo celular que utiliza un medio enriquecido con aminoácidos
EP2235056A1 (en) 2007-12-21 2010-10-06 Genentech, Inc. Crystallization of anti-cd20 antibodies
CN103396480A (zh) 2008-05-15 2013-11-20 诺沃—诺迪斯克有限公司 抗体纯化方法
JP5755136B2 (ja) * 2009-03-27 2015-07-29 旭化成メディカル株式会社 高濃度モノクローナル抗体溶液中のウイルス除去方法
US8546548B2 (en) 2009-05-27 2013-10-01 Baxter International Inc. Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
NO2462158T3 (ja) * 2009-08-06 2018-06-09
RU2571929C2 (ru) 2009-09-01 2015-12-27 Дженентек, Инк. Улучшенная очистка белка посредством модифицированного элюирования белка а

Also Published As

Publication number Publication date
MY188566A (en) 2021-12-22
US10662237B2 (en) 2020-05-26
EP2462158A1 (en) 2012-06-13
JP2013501075A (ja) 2013-01-10
JP2025003999A (ja) 2025-01-14
JP2020023491A (ja) 2020-02-13
MX2012001659A (es) 2012-04-30
BR112012002574A2 (pt) 2020-11-03
IL287431A (en) 2021-12-01
HRP20180309T1 (hr) 2018-03-23
IL273486A (en) 2020-05-31
EP3309168A1 (en) 2018-04-18
CA2770235C (en) 2021-06-29
HUE038451T2 (hu) 2018-10-29
NZ597809A (en) 2014-05-30
SG178276A1 (en) 2012-03-29
IL273486B (en) 2022-04-01
CA2770235A1 (en) 2011-03-17
PL2462158T3 (pl) 2018-05-30
US11225513B2 (en) 2022-01-18
IL217740B (en) 2020-04-30
CN106905413A (zh) 2017-06-30
DK2462158T3 (en) 2018-03-05
RU2573894C2 (ru) 2016-01-27
EP2462158B1 (en) 2018-01-10
KR20180035936A (ko) 2018-04-06
US20200347118A1 (en) 2020-11-05
RU2012108318A (ru) 2013-09-20
WO2011031397A1 (en) 2011-03-17
CN102712691A (zh) 2012-10-03
IL217740A0 (en) 2012-03-29
AU2010292897A1 (en) 2012-02-16
ZA201200626B (en) 2013-06-26
JP2016106096A (ja) 2016-06-16
KR101844859B1 (ko) 2018-05-18
SI2462158T1 (en) 2018-04-30
US20110034674A1 (en) 2011-02-10
MX346115B (es) 2017-03-08
LT2462158T (lt) 2018-03-26
PT2462158T (pt) 2018-02-23
US20220306726A1 (en) 2022-09-29
KR20130051431A (ko) 2013-05-20
JP2017206529A (ja) 2017-11-24
JP2023029853A (ja) 2023-03-07
AU2010292897B2 (en) 2016-01-07
KR20190018041A (ko) 2019-02-20
ES2662529T3 (es) 2018-04-06
US20240083980A1 (en) 2024-03-14

Similar Documents

Publication Publication Date Title
BE2015C040I2 (ja)
BRPI0925311A2 (ja)
BRPI0924307A2 (ja)
BR112012012396A2 (ja)
BR112012000607A2 (ja)
BR122021004633A2 (ja)
BR112012000665A2 (ja)
BR122017024704A2 (ja)
BR112012012487A2 (ja)
BR112012012080A2 (ja)
BR112012009703A2 (ja)
BRPI0924534A2 (ja)
BR112012001263A2 (ja)
BR122019005883A2 (ja)
BR112012000159A2 (ja)
BR112012014856A2 (ja)
NO2462158T3 (ja)
BR122017013721A2 (ja)
BRPI0924617A2 (ja)
BR112012000156A2 (ja)
BRPI0925022A2 (ja)
BR112012016234A2 (ja)
BR112012000689A2 (ja)
BRPI0925016A2 (ja)
BRPI0924020A2 (ja)